Medirom Healthcare Technologies Inc Stock Price, News & Analysis

MEDIROM (NASDAQ:MRM) announced a new treasury strategy using cryptocurrency on October 29, 2025. The board resolved to hold Worldcoin (WLD) as a reserve asset and to hold Ethereum (ETH) as a secondary asset, while maintaining cash and deposit liquidity. As of October 28, 2025, the group holds 6,840 WLD. The company plans to distribute WLD as incentives to MOTHER Bracelet users to collect large-scale vital data. MEDIROM said it will perform risk analysis at each board meeting and disclose held-asset status, policies, and risks as necessary.

MEDIROM (NASDAQ: MRM) announced that as of October 23, 2025 it surpassed 10,000 World ID verifications at Re.Ra.Ku and other wellness salons across Japan. The company plans to expand installation of the Orb verification camera to 200 stores. MEDIROM said increased World ID authentications should improve digital proof-of-human convenience and contribute to revenue growth as adoption rises.

MEDIROM MOTHER Labs (NASDAQ: MRM) approved a private placement of new shares to two officers at a Series A valuation of ¥9 billion, with funding scheduled by the end of October 2025. The capital increase is led by management investors Yoshio Uekusa and Ryo Saito to strengthen rapid decision-making and field-rooted management.

The funding will bolster the capital base and support development of an upgraded MOTHER Bracelet wearable and systems for product commercialization, while advancing domestic and international business expansion in healthcare and wellness.

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced plans to expand the deployment of World ID's authentication device "Orb" to 200 locations across its Re.Ra.Ku relaxation studios in Japan, making it the largest installation of Orbs in the country.

The company is partnering with World, a "proof of human" protocol co-founded by Sam Altman and Alex Blania, to implement this technology that verifies human authenticity without personal identification. The initial deployment of 100 Orbs is set to complete this month, followed by the expansion to 200 locations.

MEDIROM operates over 300 wellness salons nationwide under various brands including Re.Ra.Ku, Spa Re.Ra.Ku, Re.Ra.Ku PRO, Bell Epoc, and Ruam Ruam, while also maintaining a presence in HealthTech with applications like Lav® and the MOTHER Bracelet® smart tracker.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that its subsidiary, MEDIROM MOTHER Labs, has begun providing its REMONY remote health monitoring system to the Japan Ground Self-Defense Force (JGSDF). The system features the innovative MOTHER Bracelet®, a recharge-free smart tracker that uses thermoelectric generation technology.

The JGSDF's 8th Division adopted REMONY to address critical health monitoring challenges during extended missions. The system enables continuous health tracking without battery recharging, allowing commanding officers and medical staff to monitor personnel's real-time health conditions and prevent issues like heatstroke in extreme environments.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that its subsidiary MOTHER Labs' "REMONY for Driver" system has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT) as a fatigue-driving prevention device.

The REMONY system utilizes the MOTHER Bracelet for 24/7 driver health monitoring and includes a medical-supervised sleep assessment function. The certification makes the system eligible for a 50% subsidy on equipment acquisition costs, with a cap of 800,000 yen per business operator, from MLIT's approximately 1.3 billion yen subsidy program.

The system features charge-free operation, continuous health data collection, and trend analysis capabilities for preventing health-related accidents in the transportation industry.

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced its strategic entry into cryptocurrency and blockchain technology through participation in the "World" protocol, a proof-of-human authentication system. The company plans to install "Orb" authentication devices across approximately 100 Re.Ra.Ku relaxation salons, potentially reaching up to 500,000 individuals.

The initiative includes offering customers who verify their World ID approximately 8,000 Japanese yen worth of Worldcoin tokens (WLD). MEDIROM will accept WLD for Re.Ra.Ku Tickets and plans to convert up to 50% of acquired WLD into Ethereum (ETH) as part of its financial strategy. The company operates over 300 relaxation salons across Japan under various brands including Re.Ra.Ku, Spa Re.Ra.Ku, Re.Ra.Ku PRO, Bell Epoc, and Ruam Ruam.

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced a strategic partnership with Hakuhodo Inc. to join the World Network, a proof of human protocol co-founded by OpenAI creator Sam Altman. The company plans to install "Orb" verification devices in 100 Re.Ra.Ku relaxation salons by December 2025.

The initiative aims to issue 500,000 new World IDs annually, supporting the World protocol's mission to distinguish between humans and AI in the digital age. The World ID system, developed by Tools for Humanity (TFH), uses advanced camera technology to verify human authenticity while maintaining privacy. MEDIROM, which operates over 300 relaxation salons nationwide, will integrate this technology across its Re.Ra.Ku locations as part of the global deployment strategy.

MEDIROM Healthcare Technologies (NASDAQ: MRM) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company, which received a non-compliance notice on February 27, 2025, was required to maintain a minimum closing bid price of $1.00 per share for at least 10 consecutive business days. Nasdaq confirmed that from May 20 to June 3, 2025, MRM's American Depositary Shares consistently met this requirement. The company had been given until August 26, 2025, to resolve the compliance issue, and has now successfully done so ahead of the deadline. With this achievement, Nasdaq has officially closed the matter, confirming MRM's continued listing status.